This clinical trial aims to evaluate the effectiveness of a new treatment for managing chronic pain. Participants will receive either the new treatment or a placebo to compare outcomes. The study seeks to understand the treatment's impact on pain levels and quality of life.
- Who Can Participate: Adults aged 18-65 with a diagnosis of chronic pain for at least six months
- Study Details: Participants will be randomly assigned to receive either the new treatment or a placebo. The study will last for 12 weeks, with regular assessments to monitor progress
- Study Timelines and Visits: The study will begin in January 2024 and conclude in March 2024.Participants are required to attend 5 visits over the course of the study
